Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair restoration. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells, a type of fibroblast cell isolated from the hair follicle to repair and regenerate tissue. RCT-01 provides a source of collagen expressing cells to the site of injury, addressing the underlying cause of tendinosis. It has also developed an injection device, DermaPrecise, which improves the administration of its cell therapy products and certain other injectables.


TSXV:RP - Post by User

Comment by Ingiboyon Jan 26, 2021 5:36pm
125 Views
Post# 32391521

RE:RE:Wow That Was Exciting

RE:RE:Wow That Was Exciting
MetzGER wrote: Ingiboy i am sorry to say that But you Are extremes negative. Last week we were Wondering if the MainPointe Deal fail and we loose our money.
now we get an huge Update about the financial Situation of Replicel with These Investment.

at this Point we Can Be Happy that Replicel has the cash to move on - this Wasnt Safe as the Pandemic hit in!!!

now we only have One week to Wait for Corporate Update. You Said yesterday that it was only Daytrading. Today you moan about a low Stock Price which you already anticipated yesterday so i don’t get your point.

we will have to Move a Long way but at least we know that we will see this dermal injector for market approval


"we know that we will see this dermal injector for market approval[/quote]"
The question is when !!!

Oh Metzger you are flip/flopping again.  At one point you want to kill someone and then you are the LB defender.  I am simply saying yes we are getting an update next week but this week would have been more effective.  Replicel must read these blogs because all of a sudden they see the need to start tweeting again (today) to stoke the fire and support the news.....certainly doesn't hurt but the actual update will certainly have more affect..  

<< Previous
Bullboard Posts
Next >>